Articles published by Business Wire

...

Bristol Myers Squibb Presents Positive Results from Phase 3 SCOUT-HCM Trial Demonstrating Efficacy and Safety of Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

Today 11:45 EDT

From Bristol Myers Squibb

Via Business Wire

Positive Data from Phase 2 CADENCE Trial Provides Definitive Proof-of-Concept for WINREVAIR™ (sotatercept-csrk) in Adults With the Syndrome of Combined Post- and Precapillary Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction

Today 11:45 EDT

From Merck & Co., Inc.

Via Business Wire

ONON Investors Have Opportunity to Join On Holding AG Fraud Investigation with the Schall Law Firm

Today 11:30 EDT

From The Schall Law Firm

Via Business Wire

Super Micro Computer, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – SMCI

Today 8:00 EDT

From The DJS Law Group

Via Business Wire

ImmunityBio, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – IBRX

Today 7:30 EDT

From The DJS Law Group

Via Business Wire

45th College Television Awards Winners Announced by Television Academy Foundation

Today 1:14 EDT

From Television Academy Foundation

Via Business Wire

SMCI Investors Have Opportunity to Lead Super Micro Computer, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Today 0:23 EDT

From The Schall Law Firm

Via Business Wire

IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Today 0:13 EDT

From The Schall Law Firm

Via Business Wire

WMK Investors Have Opportunity to Join Weis Markets, Inc. Fraud Investigation with the Schall Law Firm

March 28, 2026

From The Schall Law Firm

Via Business Wire

EVTL Investors Have Opportunity to Join Vertical Aerospace Ltd. Fraud Investigation with the Schall Law Firm

March 28, 2026

From The Schall Law Firm

Via Business Wire

SAN Investors Have Opportunity to Join Banco Santander, S.A. Fraud Investigation with the Schall Law Firm

March 28, 2026

From The Schall Law Firm

Via Business Wire

BW Investors Have Opportunity to Join Babcock & Wilcox Enterprises, Inc. Fraud Investigation with the Schall Law Firm

March 28, 2026

From The Schall Law Firm

Via Business Wire

Kardigan Announces Positive Phase 2 Data for Tonlamarsen in Patients with Uncontrolled Hypertension Presented as Late-Breaker at ACC.26 and Simultaneously Published in JACC

March 28, 2026

From Kardigan

Via Business Wire

Debevoise Secures Second Circuit Affirmance of Dismissal of $16 billion Claim Against YPF S.A.

March 28, 2026

From Debevoise & Plimpton LLP

Via Business Wire

YRD Investors Have Opportunity to Join Yiren Digital Ltd. Fraud Investigation with the Schall Law Firm

March 28, 2026

From The Schall Law Firm

Via Business Wire

PODD Investors Have Opportunity to Join Insulet Corporation Fraud Investigation with the Schall Law Firm

March 28, 2026

From The Schall Law Firm

Via Business Wire

PRTH Investors Have the Opportunity to Join Investigation of Priority Technology Holdings, Inc. with the Schall Law Firm

March 28, 2026

From The Schall Law Firm

Via Business Wire

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting

March 28, 2026

From Incyte

Via Business Wire

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care

March 28, 2026

From Takeda Pharmaceutical Company Limited

Via Business Wire

Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session

March 28, 2026

From Corcept Therapeutics Incorporated

Via Business Wire

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis

March 28, 2026

From Galderma SA

Via Business Wire

Anumana Secures FDA Clearance for First-of-Its-Kind ECG-AI Algorithm for Early Detection of Pulmonary Hypertension

March 28, 2026

From Anumana

Via Business Wire

Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology’s 75th Annual Scientific Session and Expo

March 28, 2026

From Arrowhead Pharmaceuticals, Inc.

Via Business Wire

IBRX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that ImmunityBio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

March 28, 2026

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy™ (xanomeline and trospium chloride)

March 28, 2026

From Bristol Myers Squibb

Via Business Wire

Visa, Street Soccer USA and Bank of America to Bring Visa Street Soccer Parks to Every FIFA World Cup 2026™ Host City in the U.S.

March 28, 2026

From Visa Inc.

Via Business Wire

Nicklaus Companies LLC Closes Sale of Business to Jack Nicklaus-Backed 20 Majors, LLC

March 27, 2026

From Nicklaus Companies LLC

Via Business Wire

ADMA BIOLOGICS, INC. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

March 27, 2026

From Kirby McInerney LLP

Via Business Wire

Lantern Pharma Confirms Panna Sharma Continues to Serve as President and CEO; Alerts Investors to False Third-Party Report

March 27, 2026

From Lantern Pharma Inc.

Via Business Wire

Kolibri Global Energy Inc. Announces Director Nominees for Upcoming Shareholder Meeting

March 27, 2026

From Kolibri Global Energy Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.